Population Analysis of Escherichia coli Sequence Type 361 and Reduced Cefiderocol Susceptibility, France.
Emerg Infect Dis
; 29(9): 1877-1881, 2023 09.
Article
en En
| MEDLINE
| ID: mdl-37610183
ABSTRACT
Cefiderocol resistance is increasingly reported in New Delhi metallo-ß-lactamase-producing Enterobacterales. Genomic and phenotypic analysis of Escherichia coli sequence type 361, a primary clone causing carbapenemase spread in France, revealed mutations leading to cefiderocol resistance. Continued genomic surveillance of carbapenem-resistant Enterobacterales could clarify prevalence of cefiderocol-resistant E. coli in Europe.
Palabras clave
Texto completo:
1
Base de datos:
MEDLINE
Asunto principal:
Gammaproteobacteria
/
Escherichia coli
Tipo de estudio:
Risk_factors_studies
País/Región como asunto:
Europa
Idioma:
En
Revista:
Emerg Infect Dis
Asunto de la revista:
DOENCAS TRANSMISSIVEIS
Año:
2023
Tipo del documento:
Article